SCHEMBL23558404

SCHEMBL23558404

CCC1(CO)CC(=O)c2cc(-c3cc(-c4ccc(C(=O)O)cc4)no3)ccc2O1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ABCB1 P08183 1/20 0.51
▸ ABCC1 P33527 1/20 0.51
▸ RARA P10276 3/20 0.35
▸ RARB P10826 3/20 0.35
▸ RARG P13631 3/20 0.35
▸ RXRA P19793 1/20 0.35
▸ KDM4E B2RXH2 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ GLA P06280 1/20 0.34
▸ GAA P10253 1/20 0.34
▸ HPGD P15428 1/20 0.34
▸ CASP1 P29466 1/20 0.34
▸ CASP7 P55210 1/20 0.34
▸ HSD17B10 Q99714 1/20 0.34
▸ SIRT5 Q9NXA8 1/20 0.34
▸ NPC1 O15118 3/20 0.33
▸ RAB9A P51151 3/20 0.33
▸ CASP3 P42574 1/20 0.33
▸ SENP8 Q96LD8 1/20 0.33
▸ SENP7 Q9BQF6 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23558461 0.86 NPC1 (0.45) ABCB1ABCC1HPGDNPC1RAB9A
SCHEMBL23558568 0.84 HSD17B1 (0.46) ABCB1ABCC1RARARARBRARG
SCHEMBL23558330 0.84 RAB9A (0.40) ABCB1ABCC1ALDH1A1GAAHPGD
SCHEMBL23558442 0.83 S1PR1 (0.42) ABCB1ABCC1RARARARBRARG
SCHEMBL25863960 0.82 RARB (0.40) RARARARBRARGRXRAKDM4E
SCHEMBL25856900 0.78 MAOB (0.43) ABCB1ABCC1KDM4EGAANPC1
SCHEMBL25856895 0.78 RAB9A (0.42) ABCB1ABCC1ALDH1A1GAAHPGD
SCHEMBL23558433 0.78 HSD17B1 (0.51) ABCB1ABCC1ALDH1A1HPGDHSD17B10
SCHEMBL25863238 0.78 CXCR1 (0.40) ABCB1ABCC1ALDH1A1HPGDNPC1
SCHEMBL23558395 0.77 ABCB1 (0.38) ABCB1ABCC1RARARARBRARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210188826-A1 COMPOUNDS FOR MODULATING S1P1 ACTIVITY AND METHODS OF USING THE SAME TREVENA, INC. 2021-06-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210188826-A1 COMPOUNDS FOR MODULATING S1P1 ACTIVITY AND METHODS OF USING THE SAME S1PR1, S1PR2, S1PR3 ABCB1 3052/4885ABCC1 2927/4885RARA 2813/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback